Touting better HIV treatment, Toronto service organization closing after 42 years - CBC

Touting better HIV treatment, Toronto service organization closing after 42 years  CBC

Merck's HIV treatment meets main goal in two late-stage studies - Reuters

Merck's HIV treatment meets main goal in two late-stage studies  Reuters

A Potential Cure for AIDS: Defeating HIV With a Single Injection - SciTechDaily

A Potential Cure for AIDS: Defeating HIV With a Single Injection  SciTechDaily

Monthly HIV injection could free patients from gruelling drug regimen - Nature

Monthly HIV injection could free patients from gruelling drug regimen  Nature

HIV services in Ukraine resilient but starting to feel the strain - Aidsmap

HIV services in Ukraine resilient but starting to feel the strain  Aidsmap

WHO: access to HIV medicines severely impacted by COVID-19 as AIDS response stalls - World Health...

WHO: access to HIV medicines severely impacted by COVID-19 as AIDS response stalls  World Health Organization (WHO)

HIV positive sperm bank launched in New Zealand - News-Medical

HIV positive sperm bank launched in New Zealand  News-Medical

Excision’s EBT-101 Demonstrates Safety in Clinical Trial But Does Not Cure HIV - CRISPR Medicine ...

Excision’s EBT-101 Demonstrates Safety in Clinical Trial But Does Not Cure HIV  CRISPR Medicine News

Attrition rate of antiretroviral therapy and its influencing factors among Chinese people living ...

Attrition rate of antiretroviral therapy and its influencing factors among Chinese people living with HIV/AIDS: a meta-analysis and system review  Springer

Some children who start antiretrovirals very early may control HIV after stopping treatment - Aid...

Some children who start antiretrovirals very early may control HIV after stopping treatment  Aidsmap

So far, Poland has seen fewer Ukrainian refugees with HIV than expected - Aidsmap

So far, Poland has seen fewer Ukrainian refugees with HIV than expected  Aidsmap

Will post-treatment controllers guide us towards an HIV cure? - Aidsmap

Will post-treatment controllers guide us towards an HIV cure?  Aidsmap

After viral rebound, dolutegravir-based treatment more likely to suppress HIV - Aidsmap

After viral rebound, dolutegravir-based treatment more likely to suppress HIV  Aidsmap

Ultra-long-acting cabotegravir could be taken three times a year for HIV PrEP and treatment - Aid...

Ultra-long-acting cabotegravir could be taken three times a year for HIV PrEP and treatment  Aidsmap

Screening and early treatment reduce anal cancer risk by 57% in people living with HIV - Aidsmap

Screening and early treatment reduce anal cancer risk by 57% in people living with HIV  Aidsmap

London patient in long-term HIV remission after stem cell transplant - Aidsmap

London patient in long-term HIV remission after stem cell transplant  Aidsmap

Further evidence that recycling tenofovir in second-line treatment is effective - Aidsmap

Further evidence that recycling tenofovir in second-line treatment is effective  Aidsmap

Islatravir plus doravirine remains effective at 96 weeks - Aidsmap

Islatravir plus doravirine remains effective at 96 weeks  Aidsmap

Second-line treatment nearly nine times more expensive than first-line in upper-middle income cou...

Second-line treatment nearly nine times more expensive than first-line in upper-middle income countries  Aidsmap

Four days on, three days off HIV treatment as effective as continuous therapy, French study finds...

Four days on, three days off HIV treatment as effective as continuous therapy, French study finds  Aidsmap

What are the roles of TAF and integrase inhibitors in weight gain? - Aidsmap

What are the roles of TAF and integrase inhibitors in weight gain?  Aidsmap

Test and treat studies show high rates of HIV diagnosis, viral suppression - Aidsmap

Test and treat studies show high rates of HIV diagnosis, viral suppression  Aidsmap

Broadly neutralising antibodies may be partners for long-acting antiretrovirals - Aidsmap

Broadly neutralising antibodies may be partners for long-acting antiretrovirals  Aidsmap

Two-thirds of people living with HIV would like to try injectable treatment, according to Europea...

Two-thirds of people living with HIV would like to try injectable treatment, according to European survey  Aidsmap

Novel, twice-a-year injected drug suppresses multidrug-resistant HIV in most patients on failing ...

Novel, twice-a-year injected drug suppresses multidrug-resistant HIV in most patients on failing therapy  Aidsmap

HIV infections lowered by 30% in universal testing and treatment study - Aidsmap

HIV infections lowered by 30% in universal testing and treatment study  Aidsmap

Earlier treatment and higher CD4 counts linked to smaller HIV reservoir - Aidsmap

Earlier treatment and higher CD4 counts linked to smaller HIV reservoir  Aidsmap

Prolonged HIV suppression is possible using ibalizumab, analysis of highly drug-resistant people ...

Prolonged HIV suppression is possible using ibalizumab, analysis of highly drug-resistant people shows  Aidsmap

How an Indian tycoon fought Big Pharma to sell AIDS drugs for $1 a day - qz.com

How an Indian tycoon fought Big Pharma to sell AIDS drugs for $1 a day  qz.com

7th HIV Remission Raises Hope of Long-Lasting Treatment For More People - ScienceAlert

7th HIV Remission Raises Hope of Long-Lasting Treatment For More People  ScienceAlert

Reappearance of HIV in "Mississippi Baby" poses questions for early treatment - Aidsmap

Reappearance of HIV in "Mississippi Baby" poses questions for early treatment  Aidsmap

South Africa: dropping out of HIV care is deadly - Aidsmap

South Africa: dropping out of HIV care is deadly  Aidsmap

Oral six-month treatment for MDR-TB is safe and effective in people with HIV - Aidsmap

Oral six-month treatment for MDR-TB is safe and effective in people with HIV  Aidsmap

Poorer HIV care outcomes for those using alcohol and drugs in sub-Saharan African countries - Aid...

Poorer HIV care outcomes for those using alcohol and drugs in sub-Saharan African countries  Aidsmap

GSK snags first-in-class FDA nod for Rukobia to treat HIV patients who have few options - Fierce ...

GSK snags first-in-class FDA nod for Rukobia to treat HIV patients who have few options  Fierce Pharma

Trump order set to halt supply of HIV, malaria drugs to poor countries as part of aid freeze, sou...

Trump order set to halt supply of HIV, malaria drugs to poor countries as part of aid freeze, sources say  New York Post

Progress on 90-90-90 HIV targets shows stark gap between eastern and western Europe - Aidsmap

Progress on 90-90-90 HIV targets shows stark gap between eastern and western Europe  Aidsmap

Dolutegravir-based HIV treatment is the safest and most effective choice for pregnant women - Aid...

Dolutegravir-based HIV treatment is the safest and most effective choice for pregnant women  Aidsmap

ADVANCE trial shows dolutegravir is highly effective in South Africa - Aidsmap

ADVANCE trial shows dolutegravir is highly effective in South Africa  Aidsmap

WHO warns Trump cuts put millions of HIV patients at risk - The Independent

WHO warns Trump cuts put millions of HIV patients at risk  The Independent

Are CD4 counts still useful in the 'treat all' era? - Aidsmap

Are CD4 counts still useful in the 'treat all' era?  Aidsmap

Hepatitis C virtually eliminated in people with HIV in the Netherlands - Aidsmap

Hepatitis C virtually eliminated in people with HIV in the Netherlands  Aidsmap

Myanmar on brink of HIV treatment crisis - Frontier Myanmar

Myanmar on brink of HIV treatment crisis  Frontier Myanmar

Genetically engineered white blood cells could be the future of HIV treatment - The Verge

Genetically engineered white blood cells could be the future of HIV treatment  The Verge

New mRNA therapy shows promise in treating 'ultrarare' inherited disease - Live Science

New mRNA therapy shows promise in treating 'ultrarare' inherited disease  Live Science

Tele-harm reduction: a new approach in the US shows promise for people with HIV who inject drugs ...

Tele-harm reduction: a new approach in the US shows promise for people with HIV who inject drugs (Mandarin)  Aidsmap

Asian people with HIV gain weight after starting treatment at similar rate to other ethnic groups...

Asian people with HIV gain weight after starting treatment at similar rate to other ethnic groups (Mandarin)  Aidsmap

Lenacapavir shows continued promise for first-line treatment and highly resistant HIV (Mandarin) ...

Lenacapavir shows continued promise for first-line treatment and highly resistant HIV (Mandarin)  Aidsmap

Test-and-treat leads to sustained fall in hepatitis C in Swiss gay men with HIV (Mandarin) - Aidsmap

Test-and-treat leads to sustained fall in hepatitis C in Swiss gay men with HIV (Mandarin)  Aidsmap